Tocilizumab efficacy in a patient with positive anti-CCP chronic Lyme arthritis

被引：1
|
作者：
Hirsch, Julianna [1 ]
Rosner, Itzhak [1 ,2 ]
Rimar, Doron [1 ,2 ]
Kaly, Lisa [1 ,2 ]
Rozenbaum, Michael [1 ,2 ]
Boulman, Nina [1 ,2 ]
Slobodin, Gleb [1 ,3 ]
机构：
[1] Technion Israel Inst Technol, Dept Med, Haifa, Israel
[2] Bnai Zion Med Ctr, Dept Rheumatol, Haifa, Israel
[3] Bnai Zion Med Ctr, Dept Internal Med A, Haifa, Israel
来源：
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES | 2016年 / 8卷 / 04期
关键词：
Lyme arthritis; lyme disease; tocilizumab;
D O I：
10.4103/1947-2714.179960
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Context: Lyme arthritis, a manifestation of tick-borne Lyme disease, can prove to be refractory to classic treatment. Case Report: We present a case of a 48-year-old male, diagnosed with chronic Lyme arthritis, refractory to recurrent and prolonged courses of doxycycline, ceftriaxone, as well as hydroxychloroquine and methotrexate. The patient responded partially to tumor necrosis factor (TNF)-alpha blockade by etanercept and, finally, entered long-term remission after his treatment was switched to tocilizumab. Conclusion: Off label treatment by biologic disease modifying antirheumatic drugs can be considered in selected patients with severe antibiotic-resistant Lyme arthritis.C.
引用
收藏
页码：194 / 196
页数：3
相关论文
共 50 条
  • [41] The clinical utility of anti-CCP antibodies in a population tested for RF: Impact of including anti-CCP in the diagnostic criteria for early rheumatoid arthritis.
    Burlingame, Rufus W.
    Bender, Ana L.
    von Muhlen, Carlos A.
    Staub, Henrique L.
    de Silveira, Ines G.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S183 - S183
  • [42] Anti-CCP Positive Patients without Clinical Synovitis Progress If Ultrasound Positive
    Nam, Jackie L.
    Hensor, Elizabeth M. A.
    Hunt, Laura
    Conaghan, Philip G.
    Wakefield, Richard J.
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [43] ANTI-CCP POSITIVE INDIVIDUALS AT RISK OF PROGRESSION TO INFLAMMATORY ARTHRITIS: WHAT HAPPENS TO BIOMARKERS PRIOR TO PROGRESSION?
    Duquenne, L.
    Harnden, K.
    Garcia-Montoya, L.
    Sidhu, N.
    Nam, J.
    Mankia, K.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 524 - 525
  • [44] Anti-CCP antibodies in Brazilian children and adults with juvenile idiopathic arthritis
    S. Bacos
    S. G. Bortolozzi
    T. S. Skare
    P. F. Spelling
    S. R. R. Utiyama
    R. Nisihara
    Clinical Rheumatology, 2014, 33 : 1001 - 1003
  • [45] EVALUATION OF RHEUMATOID ARTHRITIS CASES WITH HIGH ANTI-CCP ANTIBODY LEVEL
    Suzuki, K.
    Minami, M.
    Nishio, Y.
    Hara, N.
    Nakamura, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1134 - 1135
  • [46] Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis
    Cuchacovich, M.
    Catalan, D.
    Wainstein, E.
    Gatica, H.
    Soto, L.
    Aravena, O.
    Pesce, B.
    Sabugo, F.
    Aguillon, J. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (06) : 1067 - 1073
  • [47] Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?
    Perez-Alamino, Rodolfo
    Garcia-Valladares, Ignacio
    Cuchacovich, Raquel
    Iglesias-Gamarra, Antonio
    Espinoza, Luis R.
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (09) : 1211 - 1216
  • [48] Anti-CCP antibody is a severity marker in Korean patients with rheumatoid arthritis
    Lim, M
    Choi, S
    Sheen, D
    Joo, Y
    Shim, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 204 - 204
  • [49] Adjusting for sex and anti-CCP levels in linkage analysis of rheumatoid arthritis
    Jérémie JP Lebrec
    Quinta Helmer
    Iryna Nishchenko
    Hans C van Houwelingen
    BMC Proceedings, 1 (Suppl 1)
  • [50] Anti-CCP Antibodies: an Emerging Marker for the Early Diagnosis of Rheumatoid Arthritis
    Sarah, K.
    Nadeem, A.
    INTERNATIONAL MEDICAL JOURNAL MALAYSIA, 2010, 9 (01) : 63 - 65
12345